The company declined to comment on additional speculation.
But, the company says it's just watching increased use of CBD for now. And the company is interested enough in selling CBD beverages that it also held talks with Aphria, another Canadian marijuana producer about two months ago, insiders told Bloomberg, although those negotiations apparently fell apart at some point.
The talks come as Canada prepares to legalise cannabis for recreational use, after many years of permitting it for medicinal purposes. CBD-infused beverages harness the power of the plant's cannabidiol, the non-psychoactive ingredient in marijuana purported to have various health benefits. The space is evolving quickly, " Coke spokesman Kent Landers said.
Although the drinks wouldn't be appealing to those seeking a high, however, they could be incredibly helpful to people suffering from inflammation, pain, and cramping, according to the report. Meanwhile, Coca-Cola's stock rose 0.15% to US$46.05 on the New York Stock Exchange.More news: Delta II Launch from Vandenberg
Aurora, in a separate statement, said it would not discuss business development initiatives until they were finalised, but added: "Aurora has expressed specific interest in the infused beverage space, and we intend to enter that market".
The report said there was no guarantee that talks between the companies would be successful but Aurora shares responded by soaring 22 percent. The drug is still illegal under federal law in the United States, although some states have decriminalized it.
Have you ever had a cannabis-infused drink?
In June, America's medicines regulator approved Epidiolex, a British-made epilepsy treatment that contains cannabidiol.